Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Heartport

This article was originally published in The Gray Sheet

Executive Summary

Heartport: Chief financial officer Randall Livingston tells investors at the Robertson, Stephens medical conference that his firm is planning an initial public offering for the first half of 1996. The offering, contingent on continuing good market conditions, will follow completion of Phase I trials of Heartport's port-access system for coronary artery bypass grafting (CABG) and initiation of trials evaluating its port-access system for mitral valve replacement, Livingston said. Heartport unveiled its minimally invasive system for CABG in August, and entered an agreement in September with valve manufacturer St. Jude Medical to develop a system for valve replacement ("The Gray Sheet" Sept. 18, p. 22)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005160

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel